JCO Early Release, published online ahead of print Oct 10 2016
Journal of Clinical Oncology, 10.1200/JCO.2016.69.9371
CiteULike Complore Connotea Delicious Digg Facebook Reddit Technorati Twitter What's this?
- Does Enzalutamide Really Reduce the Risk of Progression Compared With Bicalutamide in Patients With Castration-Resistant Prostate Cancer?
Mehmet Ali Nahit Şendur and Bülent Yalçın
JCO 2016 0: 201668038-680389
- Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial—There is No Significant Reduction in Death (Yet)
JCO 2016 0: 201667463-674630